Harvest Group Wealth Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-39
Closed -$1K – 156
2020
Q4
$1K Hold
39
– – ﹤0.01% 441
2020
Q3
$1K Hold
39
– – ﹤0.01% 431
2020
Q2
$0 Buy
+39
New +$699 ﹤0.01% 534
2020
Q1
– Sell
-72
Closed -$2K – 571
2019
Q4
$2K Sell
72
-1
-1% -$45 ﹤0.01% 585
2019
Q3
$3K Sell
73
-19
-21% -$883 ﹤0.01% 536
2019
Q2
$4K Buy
92
+19
+26% +$1.11K 0.01% 384
2019
Q1
$5K Buy
+73
New +$4.89K ﹤0.01% 373

Other funds holding CLB

Harvest Group Wealth Management's CLB Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Core Laboratories (CLB) in Q1 2021, closing a stake of 39 shares — an estimated $1K sold.

Harvest Group Wealth Management first reported a position in CLB in Q1 2019 and held it in 7 quarters. The position peaked at $5K in Q1 2019. 183 funds tracked by Wall St. Rank hold CLB as of Q1 2021.

  • Harvest Group Wealth Management reported no remaining Core Laboratories position as of Q1 2021 after selling out during the quarter.
  • Harvest Group Wealth Management sold 39 Core Laboratories shares in Q1 2021, an estimated $1K.
  • Harvest Group Wealth Management first reported a position in Core Laboratories in Q1 2019 and held it in 7 quarters.
  • Harvest Group Wealth Management's Core Laboratories position peaked at $5K in Q1 2019.
  • 183 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.